Roxithromycin (Roxid DPS) is a semi-synthetic macrolide antibiotic, prescribed for respiratory tract, urinary and soft tissue infections. The information provided on this page is intended to serve as ...

Munich, Germany - One month's treatment with roxithromycin slowed the progression of atherosclerosis in patients with cerebrovascular disease in a new study. Although no effect on clinical events was ...

Berlin, Germany - Another study of the macrolide antibiotic roxithromycin in the setting of acute myocardial infarction (AMI) has failed to show a benefit in improving survival or reducing the risk of ...

Roxithromycin, sometimes known as arrow-roxithromycin, is a semi-synthetic macrolide drug that works by interrupting with protein synthesis to stop bacteria from growing. Conjunctivitis, rhinitis, ...

DUBLIN--(BUSINESS WIRE)--The "Roxithromycin Sales, Price Analysis, & Sales Forecast - 2017" report has been added to ResearchAndMarkets.com's offering. Discover the growth trends of Roxithromycin by ...

Growing research activities for expanding applications of roxithromycin is projected to fuel the growth of the roxithromycin market over the forecast period. For instance, according to research by ...